Travis Block

Title: Innovations by Inventor Travis Block

Introduction

Travis Block is an accomplished inventor based in San Antonio, TX (US). He holds a total of six patents, showcasing his contributions to the field of biomedical engineering. His work primarily focuses on advancements in cardiomyocyte maturation and drug screening methodologies.

Latest Patents

Travis Block's latest patents include innovative methods for the maturation of cardiomyocytes on amniotic fluid cell-derived extracellular matrix (ECM). These methods utilize a cell-derived ECM derived in vitro from cells isolated from amniotic fluid. The patents disclose techniques for maturing immature cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) in culture, ultimately forming mature cardiomyocytes. Additionally, he has developed a cell construct comprising a monolayer of these mature cardiomyocytes on an AFC-ECM, which is useful for cardiotoxicity and proarrhythmic screening assays of drug compounds. His work also includes methods for determining the cardiotoxicity and proarrhythmic effects of drug compounds in vitro using such cell constructs.

Career Highlights

Throughout his career, Travis Block has worked with notable companies such as Stembiosys, Inc. and Monomano, Inc. His experience in these organizations has contributed significantly to his expertise in the field of cellular biology and drug development.

Collaborations

Travis has collaborated with esteemed colleagues, including Edward S. Griffey and Mary M. Navarro. These partnerships have further enhanced his research and innovation capabilities.

Conclusion

Travis Block is a prominent inventor whose work in cardiomyocyte maturation and drug screening has the potential to revolutionize biomedical research. His contributions are paving the way for advancements in drug safety and efficacy testing.